The Canadian medical device market is projected to reach $65 million by 2030, with colonoscopy devices playing a major role in the growth. Colonoscopy is a procedure used to detect and diagnose diseases of the large intestine, such as colon cancer. The procedure involves the insertion of a long, flexible tube with a camera attached to it into the rectum. The camera allows the doctor to view the inside of the large intestine and take pictures of any abnormalities.
The Canadian colonoscopy device market is expected to grow significantly over the next decade due to an aging population and an increase in the prevalence of colorectal cancer. According to Statistics Canada, the number of Canadians aged 65 and over is projected to double by 2036, which will lead to an increased demand for colonoscopy procedures. Additionally, colorectal cancer is the second leading cause of cancer death in Canada, with an estimated 26,300 new cases and 9,400 deaths in 2020. As such, there is an urgent need for improved screening and diagnosis of colorectal cancer, which will drive demand for colonoscopy devices.
The Canadian colonoscopy device market is highly competitive, with several major players competing for market share. Major players in the market include Olympus Corporation, Boston Scientific Corporation, and Medtronic plc. These companies offer a wide range of products, including endoscopes, imaging systems, and accessories. Additionally, these companies have established strong distribution networks across Canada, which has enabled them to gain a significant market share.
In addition to the major players, there are several smaller companies that are also competing in the Canadian colonoscopy device market. These companies offer innovative products that are designed to meet the specific needs of Canadian healthcare providers. For example, EndoGastric Solutions Inc. offers a balloon-based device that can be used to treat gastroesophageal reflux disease (GERD). Similarly, EndoChoice Inc. offers a range of endoscopic devices that are designed to improve patient outcomes.
The Canadian colonoscopy device market is expected to continue to grow over the next decade due to an aging population and an increase in the prevalence of colorectal cancer. The market is highly competitive, with several major players and smaller companies offering innovative products that are designed to meet the specific needs of Canadian healthcare providers. As such, it is expected that the Canadian colonoscopy device market will reach $65 million by 2030.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence: PlatoAiStream
